S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
Investor Alert: Argentina Loaded With "White Gold" Opportunity (Ad)
'The Sacrifice Zone': Myanmar bears cost of green energy
Is Sofi Financial Stock Finally Ready to Pay Off for Investors?
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Copper More Critical than Lithium? (Ad)
Closing prices for crude oil, gold and other commodities
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
The "Trojan Horse" Hiding Inside Of Biden's $2 Trillion Infrastructure Bill. (Ad)
S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
Investor Alert: Argentina Loaded With "White Gold" Opportunity (Ad)
'The Sacrifice Zone': Myanmar bears cost of green energy
Is Sofi Financial Stock Finally Ready to Pay Off for Investors?
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Copper More Critical than Lithium? (Ad)
Closing prices for crude oil, gold and other commodities
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
The "Trojan Horse" Hiding Inside Of Biden's $2 Trillion Infrastructure Bill. (Ad)
S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
Investor Alert: Argentina Loaded With "White Gold" Opportunity (Ad)
'The Sacrifice Zone': Myanmar bears cost of green energy
Is Sofi Financial Stock Finally Ready to Pay Off for Investors?
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Copper More Critical than Lithium? (Ad)
Closing prices for crude oil, gold and other commodities
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
The "Trojan Horse" Hiding Inside Of Biden's $2 Trillion Infrastructure Bill. (Ad)
S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
Investor Alert: Argentina Loaded With "White Gold" Opportunity (Ad)
'The Sacrifice Zone': Myanmar bears cost of green energy
Is Sofi Financial Stock Finally Ready to Pay Off for Investors?
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Copper More Critical than Lithium? (Ad)
Closing prices for crude oil, gold and other commodities
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
The "Trojan Horse" Hiding Inside Of Biden's $2 Trillion Infrastructure Bill. (Ad)
NASDAQ:BNR

Burning Rock Biotech - BNR Earnings Date, Estimates & Call Transcripts

$3.35
-0.11 (-3.18%)
(As of 08/9/2022 12:00 AM ET)
Add
Compare
Today's Range
$3.26
$3.40
50-Day Range
$1.75
$3.60
52-Week Range
$1.74
$22.86
Volume
171,128 shs
Average Volume
506,368 shs
Market Capitalization
$352.12 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Earnings Summary

Upcoming
Earnings Date
Aug. 31Confirmed
Actual EPS
(May. 31)
-$0.39 Missed By -$0.16
Consensus EPS
(May. 31)
-$0.23
Last Year's Q2 EPS
(5/24/2021)
-$1.65
Skip Charts & View Estimated and Actual Earnings Data

BNR Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BNR Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Burning Rock Biotech Analyst Forecasts

Current Year EPS Consensus Estimate: $-1.46 EPS
Next Year EPS Consensus Estimate: $-1.37 EPS

BNR Earnings Date and Information

Burning Rock Biotech last posted its quarterly earnings data on May 31st, 2022. The reported ($0.39) EPS for the quarter, missing the consensus estimate of ($0.23) by $0.16. The business had revenue of $21.38 million for the quarter, compared to analysts' expectations of $19.99 million. Burning Rock Biotech has generated ($1.32) earnings per share over the last year (($1.32) diluted earnings per share). Earnings for Burning Rock Biotech are expected to grow in the coming year, from ($1.46) to ($1.37) per share. Burning Rock Biotech has confirmed that its next quarterly earnings report will be published on Wednesday, August 31st, 2022. Burning Rock Biotech will be holding an earnings conference call on Wednesday, August 31st at 8:30 AM Eastern. Interested parties can register for or listen to the call..

Burning Rock Biotech Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/31/2022
(Confirmed)
 ($0.15)       
5/31/2022Q1 2022($0.23)($0.39)($0.16)($0.39)$19.99 million$21.38 million    
3/21/2022Q4 2021($0.38)($0.38)($0.38)$23.12 million    
11/16/20219/30/2021($1.61)($1.64)($0.03)($0.25)$19.65 million    
8/30/20216/30/2021($0.14)($1.96)($1.82)($0.30)$19.71 million    
5/24/20213/31/2021($1.50)($1.65)($0.15)($0.25)$16.27 million  
3/11/202112/31/2020($0.16)($0.23)($0.07)($0.23)$20.19 million  
11/20/2020Q3 2020($0.11)($0.18)($0.07)($0.18)$18.25 million
11/19/20209/30/2020($0.76)($1.22)($0.46)($0.18)$18.25 million  
8/11/2020Q2 2020($0.20)($0.38)($0.18)($0.38)$15.14 million
8/11/20206/30/2020($0.20)($0.38)($0.18)($0.38)$15.14 million  












Burning Rock Biotech Earnings - Frequently Asked Questions

When is Burning Rock Biotech's earnings date?

Burning Rock Biotech has confirmed that its next quarterly earnings data will be published on Wednesday, August 31st, 2022. Learn more on BNR's earnings history.

Did Burning Rock Biotech beat their earnings estimates last quarter?

In the previous quarter, Burning Rock Biotech (NASDAQ:BNR) missed the analysts' consensus estimate of ($0.23) by $0.16 with a reported earnings per share (EPS) of ($0.39). Learn more on analysts' earnings estimate vs. BNR's actual earnings.

How can I listen to Burning Rock Biotech's earnings conference call?

The conference call for Burning Rock Biotech's latest earnings report can be listened to online. Listen to Conference Call

How can I read Burning Rock Biotech's conference call transcript?

The conference call transcript for Burning Rock Biotech's latest earnings report can be read online. Read Transcript

How much revenue does Burning Rock Biotech generate each year?

Burning Rock Biotech (NASDAQ:BNR) has a recorded annual revenue of $79.69 million.

How much profit does Burning Rock Biotech generate each year?

Burning Rock Biotech (NASDAQ:BNR) has a recorded net income of -$125.02 million. BNR has generated -$1.32 earnings per share over the last four quarters.

What is Burning Rock Biotech's EPS forecast for next year?

Burning Rock Biotech's earnings are expected to grow from ($1.46) per share to ($1.37) per share in the next year.

More Earnings Resources from MarketBeat

Upcoming Earnings:
This page (NASDAQ:BNR) was last updated on 8/10/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.